I get that, and I'm sure the high would be subjectively different without those affects. But I have taken my fair share of kratom and have also tried yohimbine. Yohimbine was an absolutely awful fucking experience, kratom is pleasant, and easy enough to go to sleep on. And at no dosage did I get the jitteriness, paranoia, head ache, palm seating, etc associated with yohimbine and could sleep just fine even at extremely high doses...but people do say the stimulation occurs more at low doses and the opioid effects become more apparent at higher doses, so maybe its opioid action just quickly cancels out its a2a action. But I would be willing to bet if mitragynine had a novel structure and no binding studies had been done to show a2a action then no one would be calling it a stimulant, maybe it would be described as a "more activating" low potency opioid, but IME its stimulant action is exaggerated due to its association with yohimbine. I just chalked its "ceiling" effect up to its unique action on the opioid system such as its delta affinity, partial agonism, and possibly functional selectivity(or whatever is analogous to such an attribute in opioid agonists) not to say it has no a2a action, just in my personal experience the stimulation and energy provided by kratom is more reminiscent of how I used to feel on lower doses of vicadon rather than something like yohimbine or even caffeine.